This activity is part 3 of a 3-part webinar curriculum.
Click here to view accompanying resource guide to managing hyperlipidemia.
Program Description
Pharmacists often provide education to patients with hyperlipidemia about the risks and health consequences associated with untreated or undertreated low-density lipoprotein cholesterol and residual cardiovascular risk. This webinar explores how the pharmacist’s involvement in the multidisciplinary care team can facilitate evidence-based incorporation of non-statin medications into hyperlipidemia treatment regimens. Examples of pharmacist-led clinical interventions to achieve treatment goals that will be discussed include medication therapy management, guideline and treatment adherence, and medication access.
Target Audience: Community pharmacists, health system pharmacists, and specialty pharmacists
Type of Activity: Application
Release date: April 3, 2025
Expiration date: April 3, 2026
Learner level: Foundational, Intermediate
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Examine current treatment protocols using non-statin therapies and which specific patient populations with cardiovascular risk would benefit from them
- Apply patient education and counseling to management plans for optimizing medication adherence and treatment initiation in hypercholesterolemia management
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
